Publications

You can search the extensive SGC publications list with keywords from the title, authors or journal name. Your search results can be exported to an Excel file by clicking the orange XLS button next to the search filters

2026

A targetable dependency on nonsense-mediated decay for cellular homeostasis and immune control in small cell lung cancer.

Torres-Fernández LA, Boehm V, Kaufmann J, Becker JP, Garcia-Marquez M, de Bruijn B, Rumińska A, Müller C, Bosco G, Alavinejad N, Lovric L, Bihler JI, Schulte H, Davoodi P, Schöllhorn A, Weihrauch KR, Kaiser L, Ibruli O, Liu F, Androulidaki A, Wobst N, Schmiel M, Valiulis J, Maas L, D'Rozario J, Sakthivelu V, Göbel B, Touet M, Brägelmann J, Höpker K, John F, Wolf J, Knapp S, Quaas A, Cartolano M, von Karstedt S, Beleggia F, Rammensee HG, Gouttefangeas C, Schlößer HA, Riemer AB, Reinhardt HC, Gehring NH, Peifer M, Thomas RK, George J

Mol Cancer. 25(1):. doi: 10.1186/s12943-026-02750-2

Publication date: September 9, 2026

PMID: 42711693

Accelerate Your Science: Direct-to-Biology Strategies in Medicinal Chemistry.

Hiesinger K, Knapp S

J Med Chem. 69(16):19560-19592. doi: 10.1021/acs.jmedchem.6c00996

Publication date: September 1, 2026

PMID: 42679148

Targeting the RNA-Binding Site of SARS-CoV-2 NSP13 by FRASE-bot in CACHE Challenge #2.

Wang X, Mettu A, Herasymenko O, Silva M, Houliston S, Chau I, Ghiabi P, Gibson E, Perveen S, Seitova A, Schapira M, Kireev D

J Chem Inf Model. 66(16):10318-10325. doi: 10.1021/acs.jcim.6c00560

Publication date: August 31, 2026

PMID: 42670858

Fragment-Based Discovery of Fenamic Acids as Pan-Species Inhibitors of the Soluble Epoxide Hydrolase Phosphatase Domain.

Zhu WF, Feugray G, Brunst S, Messaoudi H, Yang M, Martinez-Conde N, Krämer A, Weizel L, Ehrler JMH, Kramer JS, Kaiser A, Al-Tarrass M, Pereira T, Valet M, Brunel V, Schubert-Zsilavecz M, Knapp S, Lillich FF, Hernandez-Olmos V, Duflot T, Hiesinger K, Qian H, Proschak A, Bellien J, Proschak E

ACS Chem Biol. 21(8):2053-2067. doi: 10.1021/acschembio.6c00502

Publication date: August 22, 2026

PMID: 42631699

Selective Macrocyclic WEE1 Kinase Inhibitors with Strong Efficacy against Patient-Derived Colorectal Cancer Organoids.

Syphers JL, Wright JA, Kumar A, To N, Elson L, Krämer A, Müller S, Morasch V, Chang A, Young S, Sloan EK, de Nys R, Silva TN, Vrbanac L, Barratt KR, Leeflang J, Hasan ST, Gable RW, Knapp S, Worthley DL, Mukherjee S, Stockton K, Woods SL, Priebbenow DL, Baell JB

J Med Chem. doi: 10.1021/acs.jmedchem.6c00018

Publication date: August 20, 2026

PMID: 42623604

Selective Brain-Penetrant TTBK1 Inhibitors Modulate TDP-43 Pathology and Rescue Cognitive Deficits in a Mouse Model of TDP-43 Proteinopathy.

Sanchez-Santos C, Jimenez-Amor A, Martinez-Gonzalez L, Nozal V, Martin-Morales R, Aledavood E, Bausela D, Merrigan K, Diaz-Palacios K, Zhubi R, Knapp S, Garcia-Gonzalo FR, Rodriguez-Cueto C, Gil C, de Lago E, Martinez A

J Med Chem. 69(15):19451-19481. doi: 10.1021/acs.jmedchem.6c01882

Publication date: August 13, 2026

PMID: 42593908

Hepatocyte growth factor activator inhibitor-2 rapidly inactivates airway-expressed human Type II Transmembrane Serine Proteases.

Fraser BJ, Wilson RP, Lac J, Ilyassov O, Seitova A, Li Y, Hutchinson A, Li YY, Loppnau P, Kutera M, Morin GB, Benard F, Arrowsmith CH

J Biol Chem. 113440. doi: 10.1016/j.jbc.2026.113440

Publication date: August 12, 2026

PMID: 42586429

The structural basis for LRRK2's activation and autoinhibition.

Villagran Suarez A, Hatch KS, Bodrug T, Gai W, Surridge KJ, Moussikhina E, Nguyen KHV, Sanz-Murillo M, Callahan R, Xiong E, Ramos D, Zhu L, Dederer V, Mathea S, Iwasa J, Knapp S, Shokat KM, Reck-Peterson SL, Leschziner AE

Cell. doi: 10.1016/j.cell.2026.07.027

Publication date: August 11, 2026

PMID: 42575089

Biophysical and Cellular Assays for the Evaluation of Peptidomimetic Inhibitors Based on Degron Sequences.

Lenz C, Saxena K, Knapp S

Methods Mol Biol. 3069:103-124. doi: 10.1007/978-1-0716-5508-5_7

Publication date: August 10, 2026

PMID: 42573692

Utilization of Functional Degradation Pathways for the Characterization of Ubiquitin-Proteasome System Tool Compounds.

Frischkorn JM, Riching K, Knapp S, Schwalm MP

Methods Mol Biol. 3069:33-51. doi: 10.1007/978-1-0716-5508-5_3

Publication date: August 10, 2026

PMID: 42573688

Chemogenomic sets: valuable tools for early-stage drug discovery.

Schoppa MQ, Drewry DH

Essays Biochem. doi: 10.1042/EBC20260007

Publication date: July 30, 2026

PMID: 42529985

The enabling power of chemical probes: examples from the nuclear hormone receptor field.

Willson TM, Merk D

Essays Biochem. doi: 10.1042/EBC20260016

Publication date: July 23, 2026

PMID: 42488934

An Atlas of Short Linear Motif-Mediated Human Protein-Protein Interactions.

Madhu P, Benz C, Simonetti L, Winters MJ, Subbanna MS, Kliche J, Gomez-Lucas L, Kotb HM, Krystkowiak I, Segal D, Darling WTP, Larsen-Ledet S, Vieler M, Zupancic A, Konstantinou A, Mihalic F, Varga JK, Pagano L, Lüchow S, Kraemer A, Ellingboe L, Görlitz K, Righetto GL, Kossmann C, Xiong R, Schueler-Furman O, Halabelian L, Santhakumar V, Arrowsmith C, Knapp S, Erdelyi M, Stein A, Vincentelli R, Pryciak PM, Davey NE, Ivarsson Y

bioRxiv. doi: 10.64898/2026.07.03.735260

Publication date: July 17, 2026

PMID: 42465437

Quantum Pharmacophore-Based Virtual Screening Enables Prospective Discovery of Chemotype-Diverse Dengue NS5 Inhibitors.

Martinov MN, Van Den Bergh A, Jacoby E, Kirov I, Nashev LG, Herasymenko O, Arrowsmith CH, Slater JW, Grell T, Maksimchuk K, Hack MD, Wu Z, Ohadi D, Borrenberghs D, Van Loock M, Mulakala C, Goethals O

J Chem Inf Model. doi: 10.1021/acs.jcim.6c01051

Publication date: July 16, 2026

PMID: 42462159

Fragility of precision: resistance to mutant p53 reactivation.

Joerger AC, Stiewe T

Signal Transduct Target Ther. 11(1):. doi: 10.1038/s41392-026-02830-1

Publication date: July 13, 2026

PMID: 42437754

Riding toward Selectivity: Optimization of Covalent 7-Azaindole-Based BMX Kinase Inhibitors.

Liang XJ, Albertini C, Kronenberger T, Shevchenko E, Rasch A, Berger BT, Schwalm M, Berger LM, Krämer A, Serafim RAM, Forster M, Chaikuad A, Bolognesi ML, Müller S, Poso A, Laufer S, Knapp S, Gehringer M

J Med Chem. doi: 10.1021/acs.jmedchem.6c01366

Publication date: July 13, 2026

PMID: 42441922

Site-Specific Hydrogen-Deuterium Exchange Mass Spectrometry for Deep Explorations of Dynamic Shifts in Protein-Drug Interactions.

Anacleto J, Wolf E, Ackloo S, Arrowsmith C, LeBlanc Y, Lento C, Wilson DJ

J Am Chem Soc. doi: 10.1021/jacs.6c03259

Publication date: July 9, 2026

PMID: 42420201

AURORA A interacts with DICER and SETD2 to promote S-phase progression.

Müller J, Daunke T, Berner N, Bhandare P, Gebhardt A, Hoffmann L, Diebold M, Vogt M, Hofstetter J, Cruz-Garcia Y, Dudvarski-Stankovic N, Schneider K, Adhikari B, Lamer S, Schlosser A, Büchel G, Sos ML, Küster B, Knapp S, Wilhelm S, Wolf E

EMBO Rep. doi: 10.1038/s44319-026-00850-0

Publication date: July 1, 2026

PMID: 42380670

Auto-segmentation of organs-of-interest clinical acceptability & reproducibility framework in head and neck cancer.

Marsilla J, Welch ML, Siraj J, McElcheran C, Kim JW, Tkachuck D, Kim S, Cho J, Hahn E, Hosni A, Jacinto JC, Kazmierski M, Rey-McIntyre K, Huang SH, Patel T, Tadic T, Bratman S, Hope A, Haibe-Kains B

Phys Imaging Radiat Oncol. 39:101015. doi: 10.1016/j.phro.2026.101015

Publication date: June 30, 2026

PMID: 42376454

Structure-Based Design, Synthesis, and Evaluation of Novel Ponatinib Derivatives With a Significantly Altered Selectivity Profile.

Betzholz T, Liu T, Krämer A, Dederer V, Knapp S, Mathea S, Ducho C, Engel M

ChemMedChem. 21(11):e202501007. doi: 10.1002/cmdc.202501007

Publication date: June 18, 2026

PMID: 42313448

On the Scope of DCAF1-Recruiting PROTACs Degrading Protein Kinases.

Weckesser J, Miletić N, Sivashanmugam SA, Ohmayer U, Steger M, Shashikadze B, Gehrtz P, Unzue Lopez A, Wegener A, Dietz TY, Hammann T, Hartung IV, Elson L, Němec V, Schwalm MP, Adhikari B, Wolf E, Krämer A, Müller S, Daub H, Knapp S

J Med Chem. doi: 10.1021/acs.jmedchem.6c00383

Publication date: June 17, 2026

PMID: 42304961

p21-Activated Kinase (PAK) Group I-Targeting Inhibitors Promote the Dimeric Conformation in Live Cells.

Ehret TAL, Berger BT, Raig N, Nowotka F, Manik N, Morasch V, Krämer A, Elson L, Matos TL, Müller S, Knapp S, Schwalm MP

ACS Chem Biol. doi: 10.1021/acschembio.6c00410

Publication date: June 15, 2026

PMID: 42287201

High-throughput protein target mapping enables accelerated bioactivity discovery for ToxCast and PFAS compounds.

Yang D, Wang X, Liu J, Gong Y, Nair P, Sun J, Qian X, Cui J, Zeng H, Dong A, Harding RJ, Burgess-Brown N, Beyett TS, Song D, Krause HM, Diamond ML, Bolhuis DL, Brown NG, Arrowsmith CH, Edwards AM, Halabelian L, Peng H

Proc Natl Acad Sci U S A. 123(25):e2515940123. doi: 10.1073/pnas.2515940123

Publication date: June 5, 2026

PMID: 42247526

Kinetic Fingerprints as Mechanistic and Clinical Roadmaps Across KIT Activation States.

Corrionero A, Prendiville N, Cazorla T, Baena-Nuevo M, Sandra R, Camafeita E, Knapp S, Alfonso P

ChemMedChem. 21(11):e70331. doi: 10.1002/cmdc.70331

Publication date: June 4, 2026

PMID: 42236317

A guide to selecting high-performing antibodies for ARID2 (UniProt ID: Q68CP9) for use in western blot, immunoprecipitation, and immunofluorescence.

Moleón VR, Alende C, Fothouhi M, Bolívar SG, Ayoubi R, Francis V, McPherson PS, Laflamme C

F1000Res. 15:614. doi: 10.12688/f1000research.179367.1

Publication date: June 3, 2026

PMID: 42232299

ABHD2 activity is not required for the non-genomic action of progesterone on human sperm.

Edwards M, Amaral A, Carter EM, Arnolds O, Vester K, Thrun A, Wigren E, Homan E, Ribera P, Bentley K, Haraldsson M, Theo-Emegano N, Loppnau P, Szewczyk MM, Cao MA, Barsyte-Lovejoy D, Dittmar N, Hans A, Weber M, Münchow J, Zhu WF, Temme L, Brenker C, Strünker T, Sundström M, Todd MH, Edwards AM, Lesche R, Gileadi O, Tredup C

Hum Reprod. doi: 10.1093/humrep/deag085

Publication date: May 29, 2026

PMID: 42212558

Design and Synthesis of Pyrimidino[4,5-d]Pyrimidine-Based Compounds as Potent B-RAF V600E Inhibitors.

Georgiou EA, Christopoulou K, Kalampaliki AD, Giannopoulou AF, Chatziorfanou E, Bafiti V, Krämer A, Papakyriakou A, Stravopodis DJ, Knapp S, Kostakis IK

ChemMedChem. 21(11):e70324. doi: 10.1002/cmdc.70324

Publication date: May 29, 2026

PMID: 42208521

Identification and Validation of 3-Cyano-Quinoline Ligands Targeting Integrin-Linked Kinase (ILK).

Greco FA, Abdul Azeez KR, Mitrović M, Sivashanmugam SA, Schwalm MP, Preuss F, Chatterjee D, Morasch V, Mathea S, Hanke T, Müller S, Knapp S

J Med Chem. doi: 10.1021/acs.jmedchem.5c03773

Publication date: May 26, 2026

PMID: 42185966

Identification of novel CLK1 inhibitors by computational fragment-based ligand design, co-crystallization, chemical synthesis and structure activity relationships.

Bourg S, Place M, Copin C, Chaikuad A, Robert T, Holzmann H, Müller S, Bach S, Ruchaud S, Knapp S, Buron F, Routier S, Bonnet P

Eur J Med Chem. 315:118977. doi: 10.1016/j.ejmech.2026.118977

Publication date: May 24, 2026

PMID: 42176653

In vitro screening of compounds for targeting gastric cancer with Y220C p53 mutation: a molecule combining zinc chelation and a Michael acceptor drives CDKN1 and BBC3 expression to restore a p53-dependent cytotoxicity.

Nannini S, Sieffert C, McGown A, Gao XY, Jarvis A, Kostakis GE, Galvacsi A, Kallay C, Moraru R, Baud MG, Mandel S, Balourdas DI, Joerger AC, Orvain C, Peschard S, Nion A, Mellitzer G, Lottiaux S, Spencer J, Gross I, Gaiddon C

J Enzyme Inhib Med Chem. 41(1):2638836. doi: 10.1080/14756366.2026.2638836

Publication date: May 21, 2026

PMID: 42163716

Large-scale discovery, analysis and design of protein energy landscapes.

Ferrari ÁJR, Dixit SM, Thibeault J, Garcia M, Houliston S, Ludwig RW, Notin P, Phoumyvong CM, Martell CM, Jung MD, Tsuboyama K, Carter L, Arrowsmith CH, Guttman M, Rocklin GJ

Nature. doi: 10.1038/s41586-026-10465-z

Publication date: May 14, 2026

PMID: 42129553

Targeted degradation of USP7 in solid cancer cells reveals distinct effects of deubiquitinase degraders and inhibitors.

Klink N, Urban S, Seier JA, Adhikari B, Schwalm MP, Müller J, Dorsch M, Steinbach P, Jung J, Vogt M, Kaschani F, Koch J, Führer S, Kaiser M, Schulze N, Knapp S, Wolf E, Paschen A, Grüner BM, Gersch M

Nat Commun. 17(1):. doi: 10.1038/s41467-026-72295-x

Publication date: May 14, 2026

PMID: 42129197

Comprehensive kinase inhibitor screening reveals potential therapeutic targets in canine melanoma: A Comparative Precision Oncology study.

Andriotti LA, Xavier PLP, Rochetti AL, Qazi TJ, Ferrero AT, de Francisco Strefezzi R, Gomes COMS, Dagli MLZ, Leitão A, Da Silva ER, Muller S, Fukumasu H

Res Vet Sci. 208:106246. doi: 10.1016/j.rvsc.2026.106246

Publication date: May 12, 2026

PMID: 42114276

Drugs that act on both G protein-coupled receptors (GPCRs) and kinases: potentiation of effects, side effects and general aspects of drug pleiotropy.

Ljunggren H, Sokolov A, Ballante F, Fredriksson R, Lagunas-Rangel F, Hauser AS, Knapp S, Jonsson J, Schiöth HB

Br J Pharmacol. doi: 10.1111/bph.70481

Publication date: May 11, 2026

PMID: 42108658

Targeting Activin Receptor-like Kinase 2 Using Heterobifunctional Protein Degraders.

Webb DT, Jones KL, Macabuag N, Bago R, Betts J, Bhattacharyya S, Clifton S, Tinson RAJ, Achara C, Gilbert S, Howell S, Drewry DH, Rogers R, Jones C, Ferguson KR, Bullock AN, Lindsay DM, Kerr WJ, Esmieu W

J Med Chem. doi: 10.1021/acs.jmedchem.6c00714

Publication date: May 4, 2026

PMID: 42076879

Discovery and Development of a Potent LIMK2 Isoform-Specific Degrader.

Azeez KRA, Saraswati H, Mosler T, Hanke T, Ho-Xuan H, Neder N, Sivashanmugam SA, Heinz M, Schwalm MP, Giuliani G, Rathore R, Kazi R, Kumar R, Mitrovic M, Prieto-Garcia C, Bailey HJ, Mathea S, Hummer G, Đikić I, Müller S, Stolz A, Krause DS, Knapp S

ACS Chem Biol. doi: 10.1021/acschembio.6c00137

Publication date: May 1, 2026

PMID: 42066056

DARPins as pan-reactivators of temperature-sensitive p53 cancer mutants.

Münick P, Balourdas DI, Funk JS, Yüksel B, Mavridi D, Heftel J, Dreier B, Schaefer JV, Schäfer B, Knapp S, Telatar T, Akgül B, Plückthun A, Stiewe T, Joerger AC, Dötsch V

Proc Natl Acad Sci U S A. 123(18):e2531747123. doi: 10.1073/pnas.2531747123

Publication date: April 28, 2026

PMID: 42048463

Identification of novel covalent ligands that disrupt Acetyl-Lysine binding to the SETDB1 tudor domain.

Ma J, Huang Y, Zheng T, Wang H, Li B, Liu S, Liu C, Chen X, Min J

Biochem Biophys Res Commun. 819:153815. doi: 10.1016/j.bbrc.2026.153815

Publication date: April 26, 2026

PMID: 42033939

Discovery of APO-50815, a potent WEE1 kinase inhibitor with exceptional efficacy against patient-derived colorectal cancer organoids.

Syphers JL, Wright JA, de Nys R, Silva TN, Vrbanac L, Barratt KR, Leeflang J, Hasan ST, Thomson SF, Kumar A, Krämer A, Lenz C, Gee YS, Chang A, Young S, Sloan EK, Knapp S, Worthley DL, Mukherjee S, Stockton K, Priebbenow DL, Woods SL, Baell JB

Eur J Med Chem. 312:118838. doi: 10.1016/j.ejmech.2026.118838

Publication date: April 25, 2026

PMID: 42030708

Comprehensive mass spectrometry screening-derived atlas of HDAC inhibitors reveals histone-specific acetylation changes.

Karki R, Vitorino FNL, Searfoss RM, Lempiäinen JK, Arrowsmith CH, Garcia BA

Cell Rep. 45(5):117289. doi: 10.1016/j.celrep.2026.117289

Publication date: April 24, 2026

PMID: 42030158

Structural basis of NSD2 degradation via targeted recruitment of SCF-FBXO22.

Robertson KC, Amann SJ, Liu T, Funk AV, Wang X, Grishkovskaya I, Mehmood A, Tabor JR, Norris-Drouin JL, Arrowsmith CH, Collins JL, Miao Y, Emanuele MJ, Haselbach D, James LI, Brown NG

Nat Commun. doi: 10.1038/s41467-026-72235-9

Publication date: April 24, 2026

PMID: 42026065

Structure Merging Approach Leads to New Dual Potent and Selective USP25/USP28 Inhibitors.

Hernandez-Olmos V, Patzke JV, Stone CE, Nair RK, Weller K, Sauer F, Endres E, Jamai O, Rachor L, Warmutz CH, Schwalm MP, Mitrovic M, Grenier V, Ehrler JHM, Proschak A, Heering J, Sotriffer C, Mulder MPC, Knapp S, Kisker C, Proschak E

J Med Chem. doi: 10.1021/acs.jmedchem.5c03045

Publication date: April 22, 2026

PMID: 42017948

Characterization of a C9orf72 Knockout Danio rerio model for ALS and cross-species validation of potential therapeutics screened in Caenorhabditis elegans.

Emond A, Laflamme C, Therrien M, Liao M, Maios C, Labarre A, Drapeau P, Parker JA

PLoS One. 21(4):e0346613. doi: 10.1371/journal.pone.0346613

Publication date: April 10, 2026

PMID: 41961863

Identification of E3 ligase substrates and PROTAC-induced ubiquitylation sites using proximity-based identification of ubiquitin sites (PrIUS).

Tessier TM, Maitland MER, Kutera M, Dybas JM, St-Germain J, Arrowsmith CH, Barsyte-Lovejoy D, Zhang W, Raught B, Weitzman MD

Commun Biol. doi: 10.1038/s42003-026-09964-6

Publication date: April 10, 2026

PMID: 41957433

Rational discovery of therapeutic PAK1 allosteric activators.

He Y, Bae JSH, Nowak E, Outeiral C, Nissley DA, Tumber A, Berridge G, Salah E, Wang Y, He W, Zhang H, Chen T, Tusk S, Mathea S, Wang YJ, Grassam-Rowe A, Kukura P, Schofield CJ, O'Brien DP, Pierangelini A, Churchill GC, Lanyon-Hogg T, Ke Y, Xu C, Ye T, Watkins H, Ying L, Koschinski A, Solaro RJ, Tan X, Bolla JR, Wang X, Knapp S, Deane CM, Zaccolo M, Nowotny M, Lei M

Cell. doi: 10.1016/j.cell.2026.03.008

Publication date: April 2, 2026

PMID: 41923641

A synergistic interaction between PRMT5 and LSD1 inhibitors in AML.

Param NJ, Arceci E, Fiorentino F, Pignata L, Torre D, Gutiérrez-Trejo N, Fong JY, Goy PA, Han BY, Lambona C, Di Bello E, Castiello C, Barone M, Schwarz M, Arrowsmith C, Ito K, Scherle P, Wee DKB, Ndoye S, Tabaglio T, Jeyasekharan AD, Lakshmanan M, Cirilli R, Habisch H, Madl T, Mattevi A, Valente S, Mai A, Guccione E

Sci Adv. 12(13):eaea4059. doi: 10.1126/sciadv.aea4059

Publication date: March 27, 2026

PMID: 41894488

Dual-site phosphorylation of SLX4 stabilizes the SLX4-MUS81 interface to promote mitotic SMX assembly and genome protection.

Payliss BJ, Yun HY, Doshi S, Lemak A, Tse YWE, Aprosoff CM, Houliston S, Arrowsmith CH, Wyatt HDM

Nucleic Acids Res. doi: 10.1093/nar/gkag195

Publication date: March 17, 2026

PMID: 41841343

High-affinity, structure-validated and selective macrocyclic peptide tools for chemical biology studies of Huntingtin.

Fanti R, Wolf E, Ikenoue T, Deme JC, Balakrishnan S, Keith BA, Alteen MG, Chandrasekaran R, Yadav M, Bhajiawala R, Ackloo S, Feng J, Pouladi MA, Edwards AM, Wilson DJ, Lea SM, Suga H, Harding RJ

Proc Natl Acad Sci U S A. 123(12):e2520462123. doi: 10.1073/pnas.2520462123

Publication date: March 16, 2026

PMID: 41838909

Screening assay to monitor mono-ADP-ribosylhydrolase activity of viral macrodomains in cells.

Knapp S, Weber V, Verheirstraeten M, Sabcheva A, Wright T, Herkens L, Hauser L, Hirschen L, Golzmann A, Lippok B, Krieg S, Ferraris D, Knapp S, Ladurner AG, Rossetti G, Lüscher B, Korn P

Commun Biol. 9(1):. doi: 10.1038/s42003-026-09832-3

Publication date: March 13, 2026

PMID: 41820535

Evaluation of ensilication technology for ambient DNA preservation.

Blas M, Yu C, Aghababazadeh FA, Hoelscher V, Volz M, Morales L, Jarolik K, Dong X, Dobin S, Rantasalo T, Hirvonen T, Pursiheimo JP, Laine N, Homer N, Chamoun C, Pierce W, Organick L, Fehr A, Becich M, Banal JL, Youens K, Tamminen M, Haibe-Kains B, Bedard P

NAR Mol Med. 3(1):ugag011. doi: 10.1093/narmme/ugag011

Publication date: March 9, 2026

PMID: 41797988

Displaying 1 - 50 of 1969
Download XLS